370 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Wealthspire Advisors LLC

Wealthspire Advisors LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 370 shares of the biotechnology company’s stock, valued at approximately $220,000.

Other hedge funds have also made changes to their positions in the company. Public Sector Pension Investment Board increased its position in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares in the last quarter. CIBC Asset Management Inc increased its position in shares of Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares in the last quarter. Axxcess Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth about $814,000. Soros Capital Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth about $630,000. Finally, Friedenthal Financial increased its position in shares of Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after purchasing an additional 1,231 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $525.63 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a market capitalization of $40.08 billion, a PE ratio of 135.82, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The firm’s 50 day moving average is $611.62 and its 200-day moving average is $522.09.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Finally, Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

Insiders Place Their Bets

In other news, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock valued at $5,631,561 over the last ninety days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.